Dr Philip Mortimer

How much compensation should contaminated blood victims get?

From our UK edition

The Financial Times estimated on 10 May that the impending compensation relating to the UK haemophilia treatment misadventure around 1980 will reach £12 billion. The Times has suggested the figure is £8 billion. These are very large sums indeed, and they relate to previous UK government failures to engage with a problem that the press now refers to as a scandal. ‘Scandal’ implies gross maladministration and/or professional incompetence, and the current (third) inquiry into the matter, under Judge Langstaff, now needs to resolve the problem without any further delay. Judge Langstaff has undertaken to report by the autumn of this year, and he has already recommended interim awards of compensation. The term haemophilia describes an inherited inability to coagulate blood.

Why a Covid vaccine won’t be a ‘get out of jail’ card

From our UK edition

When Covid-19 vaccines arrive, are people going to agree to have them? Most of the world’s advanced economies have chosen to suppress the circulation of the Covid virus, SarsCoV-2, by lockdown, to great economic and social cost. And each of these national choices has been predicated on the assumption that the vaccines now under development will soon be available, will be protective, and will by their general distribution prevent further circulation of the virus. A further assumption is that the negative effects of lockdown can be accommodated till then. So where are we after six months of lockdown and social distancing?